Literature DB >> 1424843

Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection.

E S Edell1, D A Cortese.   

Abstract

Photodynamic therapy has been used since 1980 at our institution for the management of cancer of the tracheobronchial tree. We identified 13 patients (14 cancers) who were thought to be surgical candidates but who elected to have photodynamic therapy. Thirteen cancers (93 percent) had a complete response to hematoporphyrin-derivative phototherapy. Ten cancers (71 percent) showed a complete response after single treatment, and three (21 percent) required a second course of therapy to achieve a complete response. Ten (77 percent) of 13 cancers have shown no local recurrence. Three patients with persistent cancer underwent surgical resection and were found not to have nodal involvement. We concluded that photodynamic therapy is an alternative to surgical resection in the management of early superficial squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424843     DOI: 10.1378/chest.102.5.1319

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

Review 1.  Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.

Authors:  A K Banerjee; P H Rabbitts; J George
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 2.  Lung cancer: Biology and treatment options.

Authors:  Hassan Lemjabbar-Alaoui; Omer Ui Hassan; Yi-Wei Yang; Petra Buchanan
Journal:  Biochim Biophys Acta       Date:  2015-08-19

Review 3.  A Surgical View of Photodynamic Therapy in Oncology: A Review.

Authors:  K Moghissi; Kate Dixon; Sally Gibbins
Journal:  Surg J (N Y)       Date:  2015-10-15

4.  Photodynamic therapy for treatment of bronchial carcinomas.

Authors:  G Sutedja; R Risse; J C Van Mourik; P E Postmus
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

Review 5.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

6.  Wavelength-dependent effect of tetra(m-hydroxyphenyl)chlorin for photodynamic therapy in an 'early' squamous cell carcinoma model.

Authors:  S A Blant; J F Theumann; M Forrer; G Wagnières; H Van Den Bergh; P Monnier
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

7.  Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma.

Authors:  L Freitag; A Ernst; M Thomas; R Prenzel; B Wahlers; H-N Macha
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

Review 8.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

9.  A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.

Authors:  Yu Wang; Yong Lin; Hui-guo Zhang; Jing Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-18       Impact factor: 4.553

10.  Evaluation of the preoperative stage and operative findings in patients with non-small cell lung cancer.

Authors:  Ademir Hadzismailović; Alen Pilav
Journal:  Bosn J Basic Med Sci       Date:  2007-08       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.